Article Per Year (5 Year)
p-Index From 2020 - 2025
0.444
P-Index
This Author published in this journals
All Journal International Journal of Public Health Excellence (IJPHE) ZAHRA: JOURNAL OF HEALTH AND MEDICAL RESEARCH
Almazhia Mahliza
Unknown Affiliation
Dentistry Health Professions Medicine & Pharmacology Nursing Public Health Veterinary

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Evaluation of Pulmonary Tuberculosis Treatment in Adult Patients at Poly of Pulmonary Diseases Army Hospital Pematangsiantar City Muharti Sanjaya; Dilla Sastia Mara; Almazhia Mahliza; Chika Ade Hendranti
International Journal of Public Health Excellence (IJPHE) Vol. 1 No. 1 (2022): Agustus 2021-January 2022 (First Release)
Publisher : PT Inovasi Pratama Internasional

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55299/ijphe.v1i1.333

Abstract

Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis and is a health problem that still needs serious attention from the government and all levels of society because it can cause death. This study aims to determine the rationale for the treatment of pulmonary tuberculosis in adult patients at the Lung Disease Polyclinic at the Siantar City Army Hospital in 2021 which refers to the National Guidelines for Tuberculosis Management of the Indonesian Ministry of Health and treatment standards from WHO. This research is a non-experimental type with a descriptive evaluative design with retrospective data collection. The study was conducted using the medical records of adult pulmonary tuberculosis patients at the outpatient installation at the Pematang Siantar City Army Hospital in 2021. The results showed that the most common cases of pulmonary tuberculosis in adult patients were male patients, namely 61.22%, the diagnosis was for each patient suspected of pulmonary tuberculosis, a chest X-ray examination and smear test were carried out, pulmonary tuberculosis was treated using two anti-tuberculosis drugs, namely OAT-kombipak and OAT-FDC, 1 case was found with a duration of administration of anti-kombipak anti-tuberculosis drugs that did not comply with standard treatment and patients who received treatment received a score recovery of 97.96% and patients who failed treatment by 2.04%.
EVALUASI PENGGUNAAN OBAT ASMA PASIEN RAWAT JALAN DI RUMAH SAKIT TK. IV. 01.07.01 PEMATANGSIANTAR PERIODE APRIL - JUNI TAHUN 2024 Almazhia Mahliza; Elia Haloho; Emi Sugesti
ZAHRA: JOURNAL OF HEALTH AND MEDICAL RESEARCH Vol. 4 No. 4 (2024): OKTOBER
Publisher : CV. ADIBA ADISHA AMIRA

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Asthma is a chronic disease of the respiratory tract characterized by inflammation, increased reactivity to various stimuli, and airway narrowing that can return spontaneously or if taking appropriate medication. Data from the Word Health Organization in 2019 stated that the number of asthma sufferers in the world reached 300 million people causing morbidity together with chronic bronchitis. This study is a type of observational study using a descriptive research design with retrospective data collection on ASMA patients at Tk. Iv Hospital. 01.07.01 Pematang Siantar. This study aims to evaluate the use of drugs in ASMA patients at Tk. Iv Hospital. 01.07.01 Pematang Siantar. The samples of this study were ASMA patient prescriptions and medical records. Recipes that will be examined are matched with medical records. The data obtained were processed with the Ms Excel computer system and then presented in a frequency distribution. Based on the results of the research conducted, the results of the evaluation of the accuracy of drug use in asthma patients, namely the right drug 96 patients reached 100%, the right patient 96 patients reached 100%, the right indication96 patients reached 100%, the right dose 96 patients reached 100% and the right method of administration 96 patients reached 100%. evaluation of the use of asthma drugs obtained 2 types of asthma drug classes, namely bronchodilators and corticosteroids.
Co-Authors Chika Ade Hendranti Dilla Sastia Mara Elia Haloho Emi Sugesti Muharti Sanjaya